Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men

Prostate Cancer and Prostatic Diseases

Volumn 11, Issue 3, 2008, Pages 252-257

  Fujimoto, K ^a   Tanaka, M ^a   Hirao, Y ^a   Nagata, Y ^b   Mori, M ^b   Miyanaga, N ^c   Akaza, H ^c   Kim, W J ^d  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE; PHYTOESTROGEN; SOYBEAN PROTEIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BEVERAGE; BLOOD ANALYSIS; BLOOD LEVEL; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; EATING HABIT; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAPAN; JAPANESE; KOREA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; SOYBEAN; VOLUNTEER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; DIET SURVEYS; EATING; HEALTH; HUMANS; ISOFLAVONES; JAPAN; KOREA; MALE; MIDDLE AGED; SOYBEANS;

EID: 50649110906     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4501030     Document Type: Article

References (35)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64.
2. Adami HO, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. In: Signorello LB, Adami HO (eds). Prostate Cancer. Oxford University Press: New York, 2002, 402p.
3. Fair WR, Fleshner NE, Heston W. Cancer of the prostate: A nutritional disease? Urology 1997; 50: 840-848.
4. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85: 1571-1579.
5. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS. Nutritional and socioeconomic factors in relation to prostate cancer mortality: A cross-national study. J Natl Cancer Inst 1998; 90: 1637-1647.
6. Eichholzer M, Stahelin HB, Ludin E, Bernasconi F. Smoking, plasma vitamins C, E, retinol, and fatal prostate cancer: Seventeen-year follow-up of the prospective basal study. Prostate 1999; 38: 189-198.
7. Clark LC, Dalkin B, Krongrad A, Combs Jr GF, Turnbull BW, Slate EH et al. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 1998; 81: 730-734.
8. Hartman TJ, Albanes D, Pietinen P, Hartman AM, Rautalahti M, Tangrea JA et al. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 1998; 7: 335-340.
9. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 1998; 9: 553-557.
10. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR et al. Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9 795-804.
11. Breinholt V, Larsen JC. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 1998; 11: 622-629.
12. Wiseman H. The therapeutic potential of phytoestrogens. Expert Opin Investig Drugs 2000; 9: 1829-1849.
13. Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA. Identification of estrogen receptor 2, a functional variant of estrogen receptor expressed in normal rat tissues. Endocrinology 1998; 139: 1082-1092.
14. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reproduct 2004; 70: 1188-1195.
15. Dechaud H, Ravard C, Claustrat F, de la Perriere AB, Pugeat M. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids 1998; 64: 328-334.
16. Martin ME, Haourigui M, Pellissero C, Benassayag C, Nunez EA. Interaction between phytoestrogens and human sex steroid binding protein. Life Sci 1996; 58: 429-436.
17. Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2003; 54: 68-78.
18. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T et al. Is daidzein non-metabolizer a high risk for prostate cancer?: A case-controlled study of serum soy beans isoflavones concentration. Jpn J Clin Oncol 2002; 32: 296-300.
19. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T et al. Comparisons of percent equol producer between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean, and American residents. Jpn J Clin Oncol 2004; 34: 86-89.
20. Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K et al. A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet. Cancer Sci 2004; 95: 238-242.
21. Toda T, Tamura J, Okuhira T. Isoflavone content in commercial foods. Foods Food Ingredients J 1997; 172: 83-88.
22. Kagawa Y. Standard Tables of Food Composition in Japan, 5th revised and enlarged edition. Kagawa Nutrition University Publishing Division: Tokyo, 2005.
23. Coward L, Kirk M, Albin N. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 1996; 247: 121-142.
24. Hentges DJ, Maier BR, Burton GC, Flynn MA, Tsutakawa RK. Effect of a high-beef diet on the fecal bacterial flora of humans. Cancer Res 1977; 37: 568-571.
25. Fingold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: composition of Japanese and American diets. Am J Clin Nutr 1974; 27: 1456-1469.
26. Tsangalis D, Ashton JF, McGill AEJ, Shah NP. Enzymic transformation of isoflavone phytoestrogens in soymilk by B-glucosidase-producing bifidobacteria. J Food Sci 2002; 67: 3104-3113.
27. Lampe JW. Isoflavonoid and lignan phytoestrogen as dietary biomarkers. J Nutr 2003; 133: 956S-964S.
28. Adlercreutz H, Honjo H, Higashi A, Totsis T, Hamalainen E, Hasegawa T et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991; 54: 1093-1100.
29. Hur HG, Beger RD, Heinze TM, Lay Jr JO, Freeman JP, Dore J et al. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch Microbiol 2002; 178 8-12.
30. Ueno T, Uchiyama S, Kikuchi N. The role of intestinal bacteria on biological effects of soy isoflavones in humans. J Nutr 2002; 132: 594S.
31. Atkinson C, Berman S, Humbert O, Lampe JW. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 2004; 134: 596-599.
32. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp Biol Med 2005; 230: 155-170.
33. Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterization of an equol-producing mixed microbial culture from a human fecal sample and its activity under gastrointestinal conditions. Arch Microbiol 2005; 183: 45-55.
34. Tsangalis D, Wilcox G, Shah NP, McGill AE, Stojanovska L. Urinary excretion of equol by postmenopausal women consuming soymilk fermented by probiotic bifidobacteria. Eur J Clin Nutr 2007; 61: 438-441.
35. Wiseman H, Casey K, Bowey EA, Duffy R, Davies M, Rowland IR et al. Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 2004; 80: 692-699.